NSE:EPIGRAL management interview: Can Epigral Become India's Next Specialty Chemicals Giant? CMD Explains | Maulik Patel | ET Now
ET Now, 2026-07-28. Video: https://www.youtube.com/watch?v=0RL9Lq1-1DA
- Caustic soda pricing: Near-term realizations remain elevated due to high energy costs, but long-term normalized Electrochemical Unit (ECU) levels are expected to stabilize between 30,000 and 32,000 per ton.
- EBITDA margin guidance: Company-wide EBITDA margins are projected to hold between 20% and 25% for the full year, supported by stronger seasonal demand for infrastructure-related chemicals in the second half.
- Capex and leverage: Expansions in epoxy resins and multipurpose plants will be funded through internal accruals and debt, with management targeting to keep the debt-to-EBITDA ratio capped at 1.5x compared to the current 0.9x level.
- Revenue growth outlook: Optimization of existing 3,200 crore investments alongside the newly announced 600 crore Capex is projected to scale total revenue capacity to approximately 5,000 crore over the next few years.